Sunflower Pharmaceutical Group Co.,Ltd

SZSE:002737 Stock Report

Market Cap: CN¥11.9b

Sunflower Pharmaceutical GroupLtd Management

Management criteria checks 2/4

We currently do not have sufficient information about the CEO.

Key information

Yi Guan

Chief executive officer

CN¥4.8m

Total compensation

CEO salary percentagen/a
CEO tenure5.8yrs
CEO ownershipn/a
Management average tenure2.9yrs
Board average tenure3.4yrs

Recent management updates

Recent updates

We Believe That Sunflower Pharmaceutical GroupLtd's (SZSE:002737) Weak Earnings Are A Good Indicator Of Underlying Profitability

Nov 04
We Believe That Sunflower Pharmaceutical GroupLtd's (SZSE:002737) Weak Earnings Are A Good Indicator Of Underlying Profitability

A Look At The Intrinsic Value Of Sunflower Pharmaceutical Group Co.,Ltd (SZSE:002737)

Aug 26
A Look At The Intrinsic Value Of Sunflower Pharmaceutical Group Co.,Ltd (SZSE:002737)

Lacklustre Performance Is Driving Sunflower Pharmaceutical Group Co.,Ltd's (SZSE:002737) Low P/E

Jul 19
Lacklustre Performance Is Driving Sunflower Pharmaceutical Group Co.,Ltd's (SZSE:002737) Low P/E

Sunflower Pharmaceutical GroupLtd's (SZSE:002737) Shareholders Will Receive A Bigger Dividend Than Last Year

Jun 07
Sunflower Pharmaceutical GroupLtd's (SZSE:002737) Shareholders Will Receive A Bigger Dividend Than Last Year

Earnings Troubles May Signal Larger Issues for Sunflower Pharmaceutical GroupLtd (SZSE:002737) Shareholders

May 06
Earnings Troubles May Signal Larger Issues for Sunflower Pharmaceutical GroupLtd (SZSE:002737) Shareholders

Sunflower Pharmaceutical Group Co.,Ltd's (SZSE:002737) Subdued P/E Might Signal An Opportunity

Apr 16
Sunflower Pharmaceutical Group Co.,Ltd's (SZSE:002737) Subdued P/E Might Signal An Opportunity

We Ran A Stock Scan For Earnings Growth And Sunflower Pharmaceutical GroupLtd (SZSE:002737) Passed With Ease

Mar 04
We Ran A Stock Scan For Earnings Growth And Sunflower Pharmaceutical GroupLtd (SZSE:002737) Passed With Ease

CEO

Yi Guan (42 yo)

5.8yrs

Tenure

CN¥4,800,000

Compensation

Ms. Yi Guan has been a Non-Independent Director of Sunflower Pharmaceutical Group Co., Ltd. since September 26, 2017 and serves as its General Manager since January 07, 2019. She was awarded the title of H...

Leadership Team

NamePositionTenureCompensationOwnership
Yi Guan
GM & Non-Independent Director5.8yrsCN¥4.80mno data
Chunhong Wu
Financial Manager2.9yrsCN¥774.90kno data
Guangguang Zhou
Board Secretary2.8yrsCN¥436.70kno data
Liang Chen
Deputy General Manager2.9yrsCN¥3.06mno data
Jin Ming Lin
Deputy General Manager4.8yrsCN¥786.00kno data
Xin Ma
Deputy General Manager2.9yrsCN¥1.36mno data
Yang Hai
Deputy General Manager2.9yrsCN¥1.41mno data

2.9yrs

Average Tenure

43yo

Average Age

Experienced Management: 002737's management team is considered experienced (2.9 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Yi Guan
GM & Non-Independent Director7.2yrsCN¥4.80mno data
Yanling Guan
Non-Independent Director10.7yrsCN¥1.18mno data
Jingshang Ren
Non-Independent Director7.2yrsCN¥50.00kno data
Yan He
Non-Employee Supervisor7.2yrsno datano data
Chunyan Na
Supervisor4.1yrsno datano data
Yuxiu Guan
Chairman5.8yrsCN¥1.20mno data
Fen Lan
Chairman of the Supervisory Board2.7yrsno datano data
Jianzhong Zhou
Non-Independent Directorless than a yearno datano data
Yang Yang
Non-Independent Directorless than a yearno datano data
Jiajun Miao
Independent Directorless than a yearno datano data
Ying Zhang
Independent Directorless than a yearno datano data
Yan Zhao
Independent directorless than a yearno datano data

3.4yrs

Average Tenure

46yo

Average Age

Experienced Board: 002737's board of directors are considered experienced (3.4 years average tenure).